Products

Products

Home page

Drug Products

News Center

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

← BACK Return

Varenicline Tablets 1.0mg

【Drug Name】

Generic Name：Varenicline Tablets

【Strength】

1.0 mg

【Approval Status】

NMPA approval No.: H20223758

【Indication】

For smoking cessation.

Refers to drug instructions for details.

威立戒互联网药品信息服务资格证书编号：（鲁）- 经营性-2022-0218

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search